Future of targeted agents in metastatic colorectal cancer

Por Burotto, Mauricio, Hartley, Marion L, Marshall, John L, Pishvaian, Michael J
Publicado em 2012

Pancreatic cancer, treatment options, and GI-4000

Por Hartley, Marion L, Bade, Najeebah A, Prins, Petra A, Ampie, Leonel, Marshall, John L
Publicado no Hum Vaccin Immunother (2015)

Pancreatic cancer, treatment options, and GI-4000

Por Hartley, Marion L, Bade, Najeebah A, Prins, Petra A, Ampie, Leonel, Marshall, John L
Publicado no Hum Vaccin Immunother (2015)

A Pilot Trial of Molecularly Tailored Therapy for Patients with Metastatic Pancreatic Ductal Adenocarcinoma

Por Tesfaye, Anteneh A., Wang, Hongkun, Hartley, Marion L., He, Aiwu Ruth, Weiner, Louis, Gabelia, Nina, Kapanadze, Lana, Shezad, Muhammad, Brody, Jonathan R., Marshall, John L., Pishvaian, Michael J.
Publicado no J Pancreat Cancer (2019)

A Phase I clinical trial of the combination of imatinib and paclitaxel in patients with advanced or metastatic solid tumors refractory to standard therapy

Por Pishvaian, Michael J., Slack, Rebecca, Koh, Eunice Y., Beumer, Jan H., Hartley, Marion L., Cotarla, Ion, Deeken, John, He, Aiwu Ruth, Hwang, Jimmy, Malik, Shakun, Firozvi, Kashif, Liu, Minetta, Elston, Beth, Strychor, Sandy, Egorin, Merrill J., Marshall, John L.
Publicado em 2012